Postdischarge Anticoagulation Use Reduces VTE Risk After COVID-19 Hospitalization
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
At APA 2024, HCPLive interviewed APA members about how DSM-5-TR classifies psychiatric disorders differently than previous iterations.
Data from the ORCA-V trial suggests cytisinicline, a plant-based medication, aids adults in quitting e-cigarettes.
Chapter 6: VABYSMO (faricimab-svoa) is a vascular endothelial growth factor (VEGF) inhibitor and angiopoietin-2 (Ang-2) inhibitor indicated for the treatment of patients with Neovascular (Wet)…
The utility of second-generation antipsychotics and clozapine has been less advantageous than it could be, Kane explained.
Lovinsky-Desir joins Lungcast on World Asthma Day to discuss community-specific burdens of disease, and emerging strategies to manage it.
Those with coexisting PsA and atopic dermatitis needed to switch to a higher number of biologics to achieve disease control.
Geneoscopy’s ColoSense received FDA approval on May 06, 2024 based on data from the phase 3 CRC-PREVENT trial.
Vitamin D concentration was significant in chronic hepatitis B virus but not hepatitis C virus infection, suggesting its potential impact on immune response.
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…